Concord Biotech Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 44.09% of Concord Biotech, FIIs hold 7.28%, DIIs hold 10.95% and the public holds 37.68%. Promoter holding rose by 0.01 percentage points from Jun 2026.
Get an alert when Concord Biotech reports results or its shareholding changes. Free account.
Promoters
44.09%
+0.01 pp QoQ
FIIs
7.28%
−0.25 pp QoQ
DIIs
10.95%
+1.58 pp QoQ
Public
37.68%
−1.36 pp QoQ
Concord Biotech shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 44.09% | 7.28% | 10.95% | 37.68% | 88,365 |
| Jun 2026 | 44.08% | 7.53% | 9.37% | 39.04% | 83,325 |
| Mar 2026 | 44.08% | 7.79% | 9.22% | 38.90% | 82,249 |
| Dec 2025 | 44.08% | 7.58% | 9.58% | 38.75% | 81,815 |
| Sep 2025 | 44.08% | 8.03% | 9.55% | 38.32% | 82,650 |
| Jun 2025 | 44.08% | 9.10% | 8.85% | 37.94% | 82,045 |
| Mar 2025 | 44.08% | 9.35% | 9.16% | 37.41% | 81,219 |
| Dec 2024 | 44.08% | 8.33% | 9.65% | 37.93% | 82,004 |
| Sep 2024 | 44.08% | 8.10% | 9.89% | 37.95% | 84,298 |
| Jun 2024 | 44.08% | 7.11% | 10.35% | 38.46% | 80,737 |
| Mar 2024 | 44.08% | 6.49% | 8.41% | 41.03% | 83,296 |
| Dec 2023 | 44.08% | 7.00% | 8.40% | 40.52% | 87,486 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹12.44k cr, the promoter group's 44.09% stake is worth ₹5.48k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Concord Biotech shareholding: common questions
What is the promoter holding in Concord Biotech?
Promoters hold 44.09% of Concord Biotech as of Sep 2026. Their stake rose by 0.01 percentage points from Jun 2026.
How much do FIIs hold in Concord Biotech?
Foreign institutional investors (FIIs) held 7.28% of Concord Biotech in Sep 2026, −0.25 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Concord Biotech?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 10.95% of Concord Biotech in Sep 2026, +1.58 pp versus Jun 2026.
Is the promoter holding in Concord Biotech pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Concord Biotech.
How has Concord Biotech's promoter holding changed in the last year?
Promoter holding moved from 44.08% in Sep 2025 to 44.09% in Sep 2026 (+0.01 pp).
How many shareholders does Concord Biotech have?
Concord Biotech had 88,365 shareholders in Sep 2026, compared with 83,325 in Jun 2026.